31-45 of 278
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
On the Frontlines of Multiple SclerosisAging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Charles Turck, PharmD, BCPS, BCCCP
Yinan Zhang, MD
Sarah A. Morrow, MD, MS, FRCPC, FAAN
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
On the Frontlines of Multiple SclerosisManaging MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Charles Turck, PharmD, BCPS, BCCCP
Kimberly DiMauro, DO
Carol Swetlik, MD
Osteoporosis in Postmenopausal Women: Sequencing Strategies and Challenges
On the Frontlines of OsteoporosisOsteoporosis in Postmenopausal Women: Sequencing Strategies and Challenges
Felicia Cosman, MD
Optimizing Anabolic and Antiresorptive Treatment Transitions for Osteoporosis
On the Frontlines of OsteoporosisOptimizing Anabolic and Antiresorptive Treatment Transitions for Osteoporosis
Felicia Cosman, MD
Preventing Osteoporosis with Hormone Therapy: How to Select Appropriate Patients
On the Frontlines of OsteoporosisPreventing Osteoporosis with Hormone Therapy: How to Select Appropriate Patients
Risa Kagan, MD, FACOG, CCD, NCMP
Menopausal Hormone Therapy for Bone Health: Balancing Benefits and Risks
On the Frontlines of OsteoporosisMenopausal Hormone Therapy for Bone Health: Balancing Benefits and Risks
Risa Kagan, MD, FACOG, CCD, NCMP
- advertisement
Menopause and Bone Health: Modern Approaches for Healthcare Providers
Boning Up on OsteoporosisMenopause and Bone Health: Modern Approaches for Healthcare Providers
Claire Gill
Andrea Singer, MD, FACP, CCD
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiersBeyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Thomas Karikari, PhD
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiersPreventing Alzheimer’s Disease Through Lifestyle Interventions
Michele Longo, MD
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiersAmyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Michele Longo, MD
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiersDebunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Clifford Jack Jr., MD
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiersReviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Clifford Jack Jr., MD
- advertisement
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiersBeyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Ashley Baker, MSN, PMHNP
Suzanne E. Schindler, MD, PhD
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
NeuroFrontiersThe BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
ECTRIMS 2024 Updates: How Menopause Impacts Women with MS
NeuroFrontiersECTRIMS 2024 Updates: How Menopause Impacts Women with MS
Riley Bove, MD, MMSc
